Feedback Inhibition
Line Loss
Energy to Drive Translocation
Increasing Function
Reducing Line Loss
Lung Capacity
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 5, 2026

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
Published on: June 28, 2018
Deshui Jia1, Arnaud Augert1, Dong-Wook Kim2
1Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
CREBBP loss accelerates small cell lung cancer (SCLC) and other neuroendocrine tumors by reducing cell adhesion. Histone deacetylase inhibitor therapy partially restores adhesion and shows promise for treating CREBBP-mutant SCLC.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: